Compare TORM plc (TRMD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TORM plc vs Zoetis Inc — how do they compare? TORM plc trades at $33.8 (market cap $3.43B), while Zoetis Inc trades at $73.83 (market cap $30.29B). The key difference: Zoetis Inc is far larger — about 8.8× TORM plc's market cap, and TORM plc pays the higher dividend (12.47%). Which is the better fit depends on your goals.
| TRMD | ZTS | |
|---|---|---|
Market Cap | $3.43B | $30.29B |
Sector | Technology | Health |
52-Week High | $35.46 | $150.61 |
52-Week Low | $19.39 | $71.91 |
Enterprise Value | $4.14B | $37.86B |
Dividend Yield | 12.47% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TRMD trades at $34.94, down 0.68% today, with a bullish technical outlook supported by moving averages. The company reported record Q2 2026 earnings with $3.25 EPS, slightly missing estimates, and maintains strong profitability with a 35.52% net income margin. A $2.40 dividend is scheduled for September 2026, reflecting robust cash generation.
Outlook is positive given low valuations (P/E 5.83, EV/EBITDA 4.45) and 100% analyst buy ratings, but risks include earnings volatility and reliance on freight rate cycles. Revenue growth to $1.8B in 2026 supports upside, though overbought RSI levels near 92 suggest near-term caution.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
